Rising to the challenge: medtech's changing faces
This article was originally published in Clinica
The medtech industry is a constant battle between established firms and emerging rivals. What do these battles tell us about strategies for maintaining or overturning an entrenched market position? Prof Brian D Smith’s research into the industry’s evolution points to three key themes and highlights companies from whom lessons can be learnt
You may also be interested in...
The pharma industry is experiencing an explosion of new business models, more numerous and specialized than we're used to. Companies need to pick the right model and adapt faster and better than their competitors. Part 3 in a series from Brian Smith's new book, Darwin's Medicine.
Where is our industry headed? Exactly where it is being pushed by what Charles Darwin called "immeasurably superior forces." Part 2 in a series from Brian Smith's new book, Darwin's Medicine.
In his forthcoming book, Darwin’s Medicine, Brian Smith argues that the emergence of new business models in the life science industry is explained by Darwin’s brilliant idea.